Ascend and Volvo Announce Autonomous Partnership
February 21, 2023 09:00 ET
|
Ascend Transportation
ATLANTA, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Ascend LLC (Ascend) – a truckload carrier that offers middle-mile supply chain solutions — today announced a commercial partnership with Volvo Autonomous...
Ascend CEO Michael McLary Named to 2023 Georgia Titan 100
January 18, 2023 14:00 ET
|
Ascend Transportation
ATLANTA, Jan. 18, 2023 (GLOBE NEWSWIRE) -- 100 CEO’s & C-level executives. They are the area’s most accomplished business leaders in their industry using criteria that includes demonstrating...
Ascend Acquires Seven-Acre Terminal in McDonough, Georgia
December 28, 2022 12:15 ET
|
Ascend Transportation
Atlanta, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Ascend LLC (Ascend) — a dry van, full truckload carrier that offers middle-mile supply chain solutions— today announced it has acquired a new terminal in...
Ascend Acquires Wisconsin-Based Fuchs Trucking
November 07, 2022 10:30 ET
|
Ascend Transportation
ATLANTA, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Ascend LLC (Ascend) today announced it has acquired Fuchs Trucking LLC (Fuchs), of Sauk City, Wisconsin. The acquisition of Fuchs offers its customers...
Ascend Set to Impress at Grand Opening in Bay Area’s Novato
May 04, 2022 09:02 ET
|
City Ventures
Novato, California, May 04, 2022 (GLOBE NEWSWIRE) -- City Ventures, California’s leading builder of eco-friendly solar all-electric homes, announced the highly-anticipated grand opening event at...
Ascend LLC Recognized as the 2021 Truckload Carrier of the Year (Small Fleet Category) by The Home Depot
March 23, 2022 15:15 ET
|
Ascend Transportation
ATLANTA, March 23, 2022 (GLOBE NEWSWIRE) -- Regional logistics provider Ascend LLC (Ascend) has been recognized as the 2021 Truckload Carrier of the Year (Small Fleet Category) by The Home Depot...
Axsome Therapeutics Completes Successful FDA Pre-NDA Meeting for AXS-05 for the Treatment of Major Depressive Disorder
July 13, 2020 07:00 ET
|
Axsome Therapeutics, Inc.
NDA submission on track for 4Q 2020 NEW YORK, July 13, 2020 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management...
Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in GEMINI Phase 3 Trial in Major Depressive Disorder
December 16, 2019 06:00 ET
|
Axsome Therapeutics, Inc.
Demonstrated rapid, durable, and statistically significant improvement in depressive symptoms as measured by MADRS total score compared to placebo (p=0.002 on primary endpoint) Statistically...
Axsome Therapeutics Announces Completion of Patient Enrollment in the ASCEND Phase 2 Trial of AXS-05 in Major Depressive Disorder
November 14, 2018 07:00 ET
|
Axsome Therapeutics, Inc.
NEW YORK, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous...
Prestigious Aspen Institute Ascend Fellowship Announces 2018 Class of Leaders
September 06, 2018 12:00 ET
|
The Aspen Institute
Washington, DC, Sept. 06, 2018 (GLOBE NEWSWIRE) -- The Aspen Institute announced today the 2018 class of Aspen Institute Ascend Fellows. The Ascend Fellowship invests in diverse, entrepreneurial...